Developer docs
API playgroundTry for free, no card

Search company profiles

Aidence

Full company profile

uuid0002glr

Namestring
Aidence
Legal namestring
Aidence
Websiteurl
aidence.com
Company typeenum
Private
Founded yearint
2015
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersAmsterdam, Netherlands
HQ citystring
Amsterdam
HQ countrystring
Netherlands
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
AI medical imaging, lung nodule detection, radiology AI software, clinical decision support, chest CT analysis
Industry3 codes
PRIMARYHDAAAEAH
Medical Imaging AI
SECONDARYHLACALAG
AI Orchestration & Imaging Analytics Platforms (Model Management/Triage)
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT
SECONDARYHLAAALAO
Digital & AI-Enabled Diagnostics (algorithmic interpretation, decision support tied to assays)
NAICS code1 code
  • Computer Systems Design and Related Services54151
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
AI Radiology Software
Revenue model1 record
1Software Subscription
TypeSubscription Recurring
Description

The company provides AI-powered clinical applications for the lung cancer pathway on a subscription basis to healthcare providers, hospitals, and radiology departments across Europe and the UK NHS.

aidence.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 2 records shown
1Veye Lung Nodules
Description

CE certified AI solution for automated lung nodule detection and quantification on chest CTs, suitable for routine clinical practice and lung cancer screening.

aidence.com
+1 more record
Core offering1 text field

Aidence develops AI-powered clinical applications for the lung cancer pathway. Its flagship product, Veye Lung Nodules, is a CE-certified deep learning solution that automatically detects, quantifies, and tracks pulmonary nodules on chest CT scans, integrating directly into the radiology PACS workflow. Veye Reporting provides standardised, customisable reports for lung cancer screening programmes. The company now operates as part of DeepHealth (subsidiary of RadNet).

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 91% sensitivity at 1 false positive per scan
+2 more records
Product overview1 text field

Aidence offers a unified AI-powered clinical application portfolio for the lung cancer pathway. The core product is Veye Lung Nodules, a CE-certified deep learning solution for automated pulmonary nodule detection and quantification on chest CT scans. This integrates directly into the radiology PACS workflow. Veye Reporting is the companion module for standardised quality reporting in lung cancer screening programmes, presenting Veye Lung Nodules results in shareable report format. The company is now part of DeepHealth (subsidiary of RadNet) and focuses exclusively on lung cancer diagnostics, with NHS deployment in the UK's Targeted Lung Health Checks programme.

Product and service2 records
1Veye Lung Nodules
CategoryAI Lung Nodule Detection Software
Description

CE-certified AI solution for automated lung nodule detection and quantification on chest CT scans. Functions as a second or concurrent reader, detecting solid and sub-solid nodules 3-30mm, providing diameter and volume measurements, growth tracking with volume doubling time, and integrating directly into the radiology PACS workflow. Deployed in hospitals across Europe and UK NHS.

2Veye Reporting
CategoryClinical Reporting Software
Description

Interactive lung nodule reporting solution for standardised quality reporting in lung cancer screening programmes. Presents Veye Lung Nodules results in a clear, customisable and shareable report format for radiology departments and screening programme operators.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership9 partners
Strategic tierCoreTypeTechnology or Integration
Description

DeepHealth is listed as a partner. DeepHealth is a subsidiary of RadNet and provides AI-powered imaging informatics solutions. Aidence notes on their homepage that 'Aidence is now DeepHealth', indicating an acquisition or merger relationship.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

RadNet is listed as a partner. DeepHealth is a subsidiary of RadNet, indicating strategic alignment in AI-powered radiology solutions.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Thirona is a research partner. Aidence, Incepto, and Thirona launched a joint clinical solution to support the expansion of lung cancer screening in Europe.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Veye was handpicked by AstraZeneca for the European PINPOINT project, aiming to increase early lung cancer diagnosis through better detection and follow-up of incidental pulmonary nodules. Also mentioned in ongoing projects section.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Incepto is listed as a partner. Aidence, Incepto, and Thirona launched a joint clinical solution to support the expansion of lung cancer screening in Europe.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

4 Ways Diagnostics is listed as a market partner, UK-based diagnostic imaging provider.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Alliance Medical is listed as a market partner, UK-based diagnostic imaging provider.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Affidea is listed as a market partner, European healthcare provider.

9TMC (Telemedicine Clinic)
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

TMC is listed as a market partner for radiology services.

aidence.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Thirona develops AI-based lung image analysis software for CT scans, including nodule detection and quantification. They are a research partner of Aidence and jointly launched a lung cancer screening solution in Europe — making them both a close peer and collaborator.

2Incepto
TypeDirect peer
Description

Incepto is a European AI radiology platform that distributes and co-develops clinical AI applications, including lung cancer screening solutions alongside Aidence and Thirona. Comparable as a European radiology AI distribution and co-development platform.

TypeDirect peer
Description

Optellum is an AI platform specifically focused on lung cancer early detection and diagnosis, including lung nodule characterization on CT. Direct overlap with Aidence's Veye Lung Nodules in clinical use case and customer segment.

TypeDirect peer
Description

Quibim provides AI-powered medical imaging analysis tools across multiple imaging modalities, with a presence in European hospital networks. Comparable as a European radiology AI vendor competing for similar hospital AI budgets.

TypeEmerging player
Description

Aidoc offers a broad suite of AI solutions for radiology workflows including chest CT analysis. While broader in scope than Aidence, they compete for the same hospital AI procurement budgets and workflow integration mindshare.

TypeEmerging player
Description

Viz.ai provides AI-powered clinical workflow tools across radiology, including chest imaging. Comparable as a radiology AI workflow vendor serving hospital systems, though with broader product scope than Aidence's lung focus.

TypeEmerging player
Description

Annalise.ai offers comprehensive AI-driven radiology decision-support tools covering chest X-ray and CT, with European and global deployment. Overlaps with Aidence on chest CT analysis and European hospital customers.

TypeBroad incumbent
Description

DeepHealth is RadNet's AI-powered health informatics platform that now owns Aidence. As the parent, it is the closest broad incumbent context — operating a portfolio of imaging AI tools across multiple specialties and customer segments.

TypeDirect peer
Description

ScreenPoint Medical develops AI for breast and other imaging analysis, with a listed integration partnership with Aidence. Comparable as a medical imaging AI vendor operating in the European hospital market.

TypeBroad incumbent
Description

Siemens Healthineers offers AI-Rad Companion, a broad radiology AI suite embedded in its imaging equipment and PACS environment. Comparable as a large incumbent offering lung/chest AI capabilities as part of a wider imaging portfolio.

Market position
Strengths3 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors5 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Aidence

AI Radiology Softwareaidence.com

Aidence firmographics

Firmographics
Name
Aidence
Legal name
Aidence
Website
https://aidence.com
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

Aidence industry classification

Industry
Product category
AI Radiology Software
NAICS
Computer Systems Design and Related Services (54151)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHDAAAEAH
Medical Imaging AI
SECONDARYHLACALAG
AI Orchestration & Imaging Analytics Platforms (Model Management/Triage)
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT
SECONDARYHLAAALAO
Digital & AI-Enabled Diagnostics (algorithmic interpretation, decision support tied to assays)

Keywords

  • AI medical imaging
  • Lung nodule detection
  • Radiology AI software
  • Clinical decision support
  • Chest CT analysis

Where Aidence is headquartered

Location

Headquarters

HQ city
Amsterdam
HQ country
Netherlands
HQ region
Europe

Offices1 record

Markets served

Aidence business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Software Subscription: The company provides AI-powered clinical applications for the lung cancer pathway on a subscription basis to healthcare providers, hospitals, and radiology departments across Europe and the UK NHS.

Distribution channels1 record

Marketing channels7 records

Aidence product offering

Product offering

Core offering

Aidence develops AI-powered clinical applications for the lung cancer pathway. Its flagship product, Veye Lung Nodules, is a CE-certified deep learning solution that automatically detects, quantifies, and tracks pulmonary nodules on chest CT scans, integrating directly into the radiology PACS workflow. Veye Reporting provides standardised, customisable reports for lung cancer screening programmes. The company now operates as part of DeepHealth (subsidiary of RadNet).

Product overview

Aidence offers a unified AI-powered clinical application portfolio for the lung cancer pathway. The core product is Veye Lung Nodules, a CE-certified deep learning solution for automated pulmonary nodule detection and quantification on chest CT scans. This integrates directly into the radiology PACS workflow. Veye Reporting is the companion module for standardised quality reporting in lung cancer screening programmes, presenting Veye Lung Nodules results in shareable report format. The company is now part of DeepHealth (subsidiary of RadNet) and focuses exclusively on lung cancer diagnostics, with NHS deployment in the UK's Targeted Lung Health Checks programme.

Differentiator

Problem solved

Functional benefit

Brands

  • Veye Lung Nodules: CE certified AI solution for automated lung nodule detection and quantification on chest CTs, suitable for routine clinical practice and lung cancer screening.
  • Veye Reporting

Products and services

  • Veye Lung Nodules CE-certified AI solution for automated lung nodule detection and quantification on chest CT scans. Functions as a second or concurrent reader, detecting solid and sub-solid nodules 3-30mm, providing diameter and volume measurements, growth tracking with volume doubling time, and integrating directly into the radiology PACS workflow. Deployed in hospitals across Europe and UK NHS.
  • Veye Reporting Interactive lung nodule reporting solution for standardised quality reporting in lung cancer screening programmes. Presents Veye Lung Nodules results in a clear, customisable and shareable report format for radiology departments and screening programme operators.

Quantifiable outcome

  • 91% sensitivity at 1 false positive per scan
  • +2 more outcomes

Companies that use Aidence

Customer profile

Named customers3 records

Segments2 records

Ideal customer profiles2 records

Aidence technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability2 records

Feature3 records

Aidence partnerships and signals

Strategic signal

Partnerships

Nine partnerships are on record, tiered core, major and minor.

  • DeepHealthcoreTechnology or IntegrationDeepHealth is listed as a partner. DeepHealth is a subsidiary of RadNet and provides AI-powered imaging informatics solutions. Aidence notes on their homepage that 'Aidence is now DeepHealth', indicating an acquisition or merger relationship.
  • RadNetcoreStrategic or Co-development PartnerRadNet is listed as a partner. DeepHealth is a subsidiary of RadNet, indicating strategic alignment in AI-powered radiology solutions.
  • ThironamajorStrategic or Co-development PartnerThirona is a research partner. Aidence, Incepto, and Thirona launched a joint clinical solution to support the expansion of lung cancer screening in Europe.
  • AstraZenecamajorStrategic or Co-development PartnerVeye was handpicked by AstraZeneca for the European PINPOINT project, aiming to increase early lung cancer diagnosis through better detection and follow-up of incidental pulmonary nodules. Also mentioned in ongoing projects section.
  • InceptomajorStrategic or Co-development PartnerIncepto is listed as a partner. Aidence, Incepto, and Thirona launched a joint clinical solution to support the expansion of lung cancer screening in Europe.
  • 4 Ways DiagnosticsminorChannel Partner/ Reseller/ Distributor4 Ways Diagnostics is listed as a market partner, UK-based diagnostic imaging provider.
  • Alliance MedicalminorChannel Partner/ Reseller/ DistributorAlliance Medical is listed as a market partner, UK-based diagnostic imaging provider.
  • AffideaminorChannel Partner/ Reseller/ DistributorAffidea is listed as a market partner, European healthcare provider.
  • TMC (Telemedicine Clinic)minorChannel Partner/ Reseller/ DistributorTMC is listed as a market partner for radiology services.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Aidence competitors and assessment

Company assessment

Direct peers

  • Thirona: Thirona develops AI-based lung image analysis software for CT scans, including nodule detection and quantification. They are a research partner of Aidence and jointly launched a lung cancer screening solution in Europe — making them both a close peer and collaborator.
  • Incepto: Incepto is a European AI radiology platform that distributes and co-develops clinical AI applications, including lung cancer screening solutions alongside Aidence and Thirona. Comparable as a European radiology AI distribution and co-development platform.
  • Optellum: Optellum is an AI platform specifically focused on lung cancer early detection and diagnosis, including lung nodule characterization on CT. Direct overlap with Aidence's Veye Lung Nodules in clinical use case and customer segment.
  • Quibim: Quibim provides AI-powered medical imaging analysis tools across multiple imaging modalities, with a presence in European hospital networks. Comparable as a European radiology AI vendor competing for similar hospital AI budgets.
  • ScreenPoint Medical: ScreenPoint Medical develops AI for breast and other imaging analysis, with a listed integration partnership with Aidence. Comparable as a medical imaging AI vendor operating in the European hospital market.

Emerging players

  • Aidoc: Aidoc offers a broad suite of AI solutions for radiology workflows including chest CT analysis. While broader in scope than Aidence, they compete for the same hospital AI procurement budgets and workflow integration mindshare.
  • Viz.ai: Viz.ai provides AI-powered clinical workflow tools across radiology, including chest imaging. Comparable as a radiology AI workflow vendor serving hospital systems, though with broader product scope than Aidence's lung focus.
  • Annalise.ai: Annalise.ai offers comprehensive AI-driven radiology decision-support tools covering chest X-ray and CT, with European and global deployment. Overlaps with Aidence on chest CT analysis and European hospital customers.

Broad incumbents

  • DeepHealth (RadNet subsidiary): DeepHealth is RadNet's AI-powered health informatics platform that now owns Aidence. As the parent, it is the closest broad incumbent context — operating a portfolio of imaging AI tools across multiple specialties and customer segments.
  • Siemens Healthineers (AI-Rad Companion): Siemens Healthineers offers AI-Rad Companion, a broad radiology AI suite embedded in its imaging equipment and PACS environment. Comparable as a large incumbent offering lung/chest AI capabilities as part of a wider imaging portfolio.

Market position

Strengths3 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

Aidence social profiles

Digital presence

Aidence compliance and trust

Trust signal

Compliance4 records

Aidence financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Aidence leadership team

Management profile

Number of profiles

Profiles5 records

Aidence funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors5 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Aidence M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Aidence

What does Aidence do?

Aidence develops AI-powered clinical applications for the lung cancer pathway. Its flagship product, Veye Lung Nodules, is a CE-certified deep learning solution that automatically detects, quantifies, and tracks pulmonary nodules on chest CT scans, integrating directly into the radiology PACS workflow. Veye Reporting provides standardised, customisable reports for lung cancer screening programmes. The company now operates as part of DeepHealth (subsidiary of RadNet).

Is Aidence a public or private company?

Aidence is a private company. It is classified as corporate owned and is currently operating.

When was Aidence founded?

Aidence was founded in 2015. It employs 11 to 50 people.

Where is Aidence based?

Aidence is headquartered in Amsterdam, Netherlands, in the Europe region.

How does Aidence make money?

One revenue line is on record: software Subscription.

Who are Aidence's main competitors?

Direct peers on record are Thirona, Incepto, Optellum, Quibim and ScreenPoint Medical. Emerging players are Aidoc, Viz.ai and Annalise.ai. Broad incumbents are DeepHealth (RadNet subsidiary) and Siemens Healthineers (AI-Rad Companion).

Does Aidence have an API?

No public API is recorded for Aidence.

What industry is Aidence in?

Aidence's product category is AI Radiology Software. Its primary akta.pro industry code is HDAAAEAH, Medical Imaging AI, with a secondary code of HLACALAG, AI Orchestration & Imaging Analytics Platforms (Model Management/Triage). Its NAICS code is 54151 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
EIN Presswire26 letters ,26 Chapters ,Released 5/26/26- After Tragedy, The Author Says This Self-Help Book is Not a CoincidenceBerthille Metoua released her debut book 'The ABCs of Classy' on May 26, 2026, with 26 chapters for each letter of the alphabet. The author, who rebuilt herself after losing both parents and her husband, says the release date was intentional. She is working on four follow-up books and a novel.National Center for Biotechnology InformationNavigating regulatory and policy challenges for AI enabled combination devicesA review examines regulatory and policy challenges for AI-enabled combination devices, comparing the US FDA's 510(k) pathway and the EU's Medical Device Regulation, which both struggle with adaptive algorithms. It cites IDx-DR, HeartFlow FFRct and Aidenc's Veye as case studies, and notes 32 FDA AI-related device experiences from 2021 to June 2024. The authors call for adaptive frameworks covering transparency, accountability, collaboration and patient-centeredness.GlobeNewswireRadNet’s Aidence Artificial Intelligence (AI) Subsidiary and Google Health Enter into Collaboration to Help Improve Lung Cancer Screening with AI SolutionsRadNet's Aidence and Google Health announced a collaboration to license Google Health's AI model for lung nodule malignancy prediction on CT imaging. Aidence will develop and validate the model for early lung cancer diagnosis, with the application pending regulatory approval. The partnership aims to reduce unnecessary procedures in screening programs.GlobeNewswireRadNet Completes the acquisitions of Aidence Holding B.V. and Quantib B.V. to Address Opportunities in Lung and Prostate Cancer Diagnosis and Screening with Artificial IntelligenceRadNet completed acquisitions of Aidence and Quantib, adding AI tools for lung and prostate cancer screening. Aidence's lung nodule detection is pending FDA clearance, while Quantib's prostate MRI solution has FDA 510(k) clearance. The companies will join RadNet's AI division to expand screening offerings.NorthzoneAidence gets acquired by RadNet: How an AI company makes a great business out of saving livesRadNet, a NASDAQ-listed diagnostic imaging leader, acquired Aidence, an AI imaging solution for oncology. The acquisition will enable Aidence to scale its service faster and more internationally. The company aims to save thousands of lives by improving lung cancer screening and monitoring.GlobeNewswireRadNet Completes the acquisitions of Aidence Holding B.V. and Quantib B.V. to Address Opportunities in Lung and Prostate Cancer Diagnosis and Screening with Artificial IntelligenceRadNet acquired Dutch AI companies Aidence and Quantib to expand its AI portfolio for lung and prostate cancer screening. Aidence's lung nodule detection product is pending FDA clearance, while Quantib's prostate and brain MRI solutions have FDA 510(k) clearance. The acquisitions aim to enable large-scale screening programs for the three most prevalent cancers.FinSMEsAidence Raises €10M in Series A FundingAidence, an Amsterdam-based medical imaging startup, raised €10M in Series A funding led by Inkef Capital, bringing total funding to €12.5M. The company will use the funds for European expansion, FDA clearance for US entry, and new avenues for its Veye platform. Veye Chest is installed in over 10 hospitals across the Netherlands, UK, and Scandinavia.